Company / Cash per Share
Akebia Therapeutics, Inc. Cash per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.82
FY2025
5-year range
$0.23 / $1.54
FY2021-FY2025
Trend
+208.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +208% YoY in FY2025, a notable deviation from the 9-year average annual change of +46%.
Based on SEC 10-K filings.
0.82 in FY2025 with a 10-year CAGR of -2.3%.
Improved from $0.23 to $0.82 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +17.2%
- 5-Year CAGR
- -7.5%
- 10-Year CAGR
- -2.3%
Key checks
Key Insights
- In FY2025, cash per share increased 208.4% year-over-year.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.82 | +208.4% |
| FY2024 | $0.27 | +14.4% |
| FY2023 | $0.23 | -54.4% |
| FY2022 | $0.51 | -66.9% |
| FY2021 | $1.54 | +27.5% |
| FY2020 | $1.21 | +101.9% |
| FY2019 | $0.60 | -84.7% |
| FY2018 | $3.93 | +277.8% |
| FY2015 | $1.04 | -12.2% |
| FY2014 | $1.19 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026